MenPF-1 - A New Vaccine Against Meningococcal Disease

Inclusion Criteria: * Willing and able to give informed consent for participation in the study * Aged between 18 and 50 years * In good health as determined by medical history, physical examination and clinical judgment of the investigators * (Females) Willing to use effective contraception (such as the oral contraceptive pill, contraceptive implant or barrier methods) from one month prior and for the duration of the study * Able to attend the scheduled visits and to comply with all study procedures, including internet access for the recording of diary cards * Willing to allow his or her General Practitioner and/or Consultant, if appropriate, to be notified of participation in the study * Confirmation from GP that they are aware of the inclusion and exclusion criteria and are satisfied from their knowledge of the volunteer that they are suitable to enrol Exclusion Criteria: * History of significant organ/system disease that could interfere with trial conduct or completion * Have any known or suspected impairment or alteration of immune function * Study significant abnormalities on screening investigations at the discretion of an Investigator * Receipt of a live vaccine within 4 weeks prior to vaccination or a killed vaccine within 7 days prior to vaccination * Plan to receive any vaccine other than the study vaccine within 4 weeks following vaccination * Scheduled procedures requiring general anaesthesia during the study * Participant who is terminally ill * Receipt of imm…